Internal Medicine, Cardiovascular Disease · Santa Cruz, CA
NPI
1740335090
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1595 Soquel Dr
Santa Cruz, CA, 95065
Phone (831) 761-1680
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
14,105 services
Medicare patients, 2024
1,585
Average age 77
Drug cost, 2024
$2.4M
10,776 prescriptions
Company payments, 2025
$1,847
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benjamin N Potkin was code 99214 (office e&m - established), 3,563 times for 1,407 patients. In total Benjamin N Potkin billed 14,105 services in 51 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 3,563 | 1,407 | $87.70 | $312K |
| 93000 Electrocardiogram | Office | 2,952 | 1,322 | $9.95 | $29K |
| 93306 Echocardiography (TTE/TEE) | Office | 779 | 731 | $150.97 | $118K |
| 93229 Electrocardiogram | Office | 757 | 730 | $692.89 | $525K |
| 93228 Electrocardiogram | Office | 757 | 730 | $17.64 | $13K |
| 93224 Electrocardiogram | Office | 749 | 721 | $47.21 | $35K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 710 | 706 | $140.67 | $100K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 412 | 103 | $6.73 | $2,774 |
| 93298 External Electrocardiographic Monitoring | Office | 376 | 41 | $24.16 | $9,082 |
| 93970 Duplex Scan - Extremity Veins | Office | 271 | 266 | $141.94 | $38K |
| 93925 Duplex Scan - Extremity Arteries | Office | 263 | 256 | $192.14 | $51K |
| 99213 Office E&M - Established | Office | 216 | 199 | $67.88 | $15K |
| 93351 Echocardiography (TTE/TEE) | Office | 200 | 199 | $187.22 | $37K |
| 93297 External Electrocardiographic Monitoring | Office | 175 | 18 | $20.36 | $3,562 |
| 99204 Office E&M - New | Office | 170 | 170 | $107.92 | $18K |
By year: 2022 $2.1M for 15,680 services; 2023 $1.7M for 15,123 services; 2024 $1.5M for 14,105 services.
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin N Potkin prescribed most often to Medicare patients was Metoprolol Succinate, with 1,108 prescriptions and refills. In total Benjamin N Potkin wrote 10,776 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,108 | 2,869 | 312 | $15K |
| Atorvastatin Calcium Generic | 989 | 2,714 | 279 | $9,362 |
| Eliquis Apixaban | 961 | 1,905 | 249 | $1.1M |
| Valsartan Generic | 514 | 1,453 | 155 | $19K |
| Amlodipine Besylate Generic | 477 | 1,291 | 149 | $3,703 |
| Losartan Potassium Generic | 466 | 1,277 | 141 | $4,179 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 428 | 1,040 | 120 | $16K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 375 | 1,016 | 105 | $7,039 |
| Torsemide Generic | 366 | 947 | 134 | $6,593 |
| Hydralazine Hcl Generic | 301 | 695 | 77 | $4,080 |
| Rosuvastatin Calcium Generic | 263 | 736 | 71 | $4,321 |
| Xarelto Rivaroxaban | 254 | 527 | 65 | $294K |
| Spironolactone Generic | 237 | 662 | 75 | $2,060 |
| Clopidogrel Clopidogrel Bisulfate | 198 | 510 | 63 | $2,579 |
| Repatha Sureclick Evolocumab | 185 | 359 | 39 | $204K |
Brand drugs: 2,027 claims; generic drugs: 8,749 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Benjamin N Potkin $1,847 ($1,847 in general payments such as food, travel and fees) from 14 companies. The largest payer was Novo Nordisk Inc with $569.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 19 | $569 |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $272 |
| Amgen Inc. AMGN | 9 | $179 |
| Pfizer Inc. PFE | 11 | $172 |
| Biotronik Inc. | 9 | $135 |
| Cleerly, Inc. | 1 | $101 |
| Merck Sharp & Dohme LLC MRK | 4 | $95.2 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $80.85 |
| Boston Scientific Corporation BSX | 3 | $75.08 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $42.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.